SSTI Flashcards

1
Q

Boundary Membrane Concept

A
  • Exists on external aspects of body
  • Consists of layer(s) epithelial cells bound to each other by tight junctions, overlies a basement membrane
  • Provides water tight barrier
  • Separates epithelium from underlying connective tissue space
  • Microbial organisms live on the barrier membrane
  • Kept outside of the interstitium by the barrier membrane
  • No immune response is provoked
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Barrier Violation

A
  • Injury to the boundary membrane allows microbial penetration into interstitium
  • Bacterial virulence can be variable, from severe to minimal
  • Contamination or infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Uncomplicated SSTIs

A
  • Superficial: cellulitis, impetiginous lesions, furnucles, simple abscesses
  • Treatment usually requires antibiotics and/or simple incision and drainage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Complicated SSTI

A
  • Deep soft tissue infections: extreme pain, violaceous bullae, cutaneous hemorrhage, skin sloughing, rapid progression, gas in tissue
  • May require surgical intervention: infected ulcers, infected burns, and major abscesses
  • Significant underlying disease which complicates the response to treatment
  • May require extensive surgical debridement and reconstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Microbiology of SSTIs

A
  • S. aureus ~50%
  • Strept. pyogenes
  • Site specific infections: indigenous organisms
  • Immunocompromised + Complicated SSTIs: multiple/uncommon organisms
  • Polymicrobial necrotizing fasciitis: mixed infections with anaerobes and aerobes
  • Monomicrobial necrotizing fasciitis: S. pyogenes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Abscesses + Antibiotics Indications

A
  • Antibiotics not necessary for most: usually just drain and wound care
  • Signs of infection: fever, elevated WBCs, left shift, septic shock
  • Cellulitis or phlegmon
  • Immunocompromised
  • Certain foreign bodies (Marlex mesh)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cellulitis

A
  • Spreading infection affecting epidermis and dermis

- Common pathogen: GAS, S. aureus, Group B/C/G strept

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cellulitis Presentation

A
  • Swelling
  • Redness
  • Edema
  • Pain
  • Nonelevated
  • Poorly defined margins
  • Lymphadenopathy
  • Fever/chills: rare unless chronic, underlying disease, or immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SSTI General Treatment Rules

A

-Antibiotic therapy: 10-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Purulent SSTI Treatment

A
  • Mild Infection: purulent SSTI, incision and drainage indicated
  • Moderate: patients with purulent infection with systemic signs of infection
  • Severe: failed incision/drainage plus oral antibiotics or those with severe systemic signs, immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Severe Systemic Signs

A
  • > 38 C Fever
  • Tachycardia
  • Tachypnea
  • Abnormal WBC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nonpurulent SSTI Treatment

A
  • Mild Infection: typical cellulitis/erysipelas with no focus of purulence
  • Moderate: typical cellulitis/erysipelas with systemic signs of infection
  • Severe: failed oral antibiotic/systemic signs of infection, immunocompromised, signs of deeper infection like bullae, sloughing, hypotension, or evidence of organ dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Erysipelas

A
  • Distinct type of superficial cellulitis with extensive lymphatic involvement
  • Almost always GAS
  • Common in infants, young kids, elderly, and patients with nephrotic syndrome
  • Manifestation: lesion with sharp, elevated border, on face/scalp/hands/genitalia, fever and leukocytosis
  • Treatment: Mild/moderate non-purulent SSTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Impetigo

A
  • Superficial cellulitis by GAS (honey crust, non-bullous) and/or S. aureus (bullous, ruptured)
  • Common in children during hot/humid weather
  • Spread through close contact and little to no signs of systemic infection
  • Small, fluid-filled vesicles that develop into puss-filled blisters that rupture and crust, pruritus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Impetigo Treatment

A
  • Depends on number of lesions, location, and need to limit spread
  • Topical: mupirocin ointment to lesions TID
  • Oral: numerous lesions, location prevents topical use, or not responding to topicals
  • See moderate treatment for purulent SSTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Necrotizing Fasciitis

A
  • SC infection that tracks along fascial planes and extends beyond superficial infection signs
  • Extension from a lesion in 80% of cases
  • Presentation: cellulitis which can advance rapidly with systemic toxicity (high fevers, lethargy, confusion), cellulitis, edema, skin discoloration or gangrene
  • Usually lower extremities
17
Q

Necrotizing Fasciitis Etiology

A
  • Monomicrobial: GAS, S. aureus, Clostridium spp. (mortality in 50-70% in pts. with hypotension/organ failure
  • Polymicrobial: average of 5 per wound usually from surgical wounds, ulcers, or abscess
18
Q

Necrotizing Fasciitis Diagnosis

A
  • Clinical judgement
  • Incision and probing if no resistant to SC probing then Nec. Fasciitis
  • Gram-stain and culture
19
Q

Necrotizing Fasciitis Treatment

A

-Prompt surgical debridement

Antibiotic Options

  • PCN G 24 mU/day IV + Clinda 900 IV q8h (eagle effect)
  • MRSA suspected: Add vanco (trough 15-20 mcg/mL)
  • Polymicrobial: Vanco + Zosyn 3.375-4.5g IV q6-8h OR Imipenem 500 mg IV q6h OR Meropenem 1g IV q8h
20
Q

DFI

A
  • Diabetic Foot Infections
  • 15-20% of diabetics will get hospitalized for this
  • Requires attention to local and systemic aspects
  • Aerobic, Gram “+” are most common (S. aureus)
  • Can get Gram “-“ with chronic infections and may be anaerobes if ischemia/gangrene arises
  • Optimal DFI management can reduce infection related morbidity and the need/duration of hospitalization
21
Q

DFI Risk Factors

A
  • Neuropathy
  • Angiopathy and ischemia
  • Immunologic defects
22
Q

DFI Presentation

A
  • Polymicrobial in nature
  • Often more extensive than they appear with paronychia, middle foot, toe web, mal perforans puncture wounds
  • May be complicated by necrotizing cellulitis, osteomyelitis
23
Q

DFI Treatments

A
  • Local wound care
  • Immobilization
  • Drainage and debridement
  • Control of hyperglycemia
  • Antibiotics: ORal v.s. IV for 2 weeks (6 for osteomyelitis)
  • Amputation is LAST resort
24
Q

DFI Grades

A
  • Grade 1-2: non-limb threatening
  • Grade 3: Possibly limb threatening
  • Grade 4: Limb threatening
25
Q

DFI Treatment Administration/Duration

A
  • Mild: topical or oral, outpatient, 1-2 weeks and can extend to 4 weeks if slow to resolve
  • Moderate: Oral, outpatient or inpatient, 1-3 weeks
  • Severe: initiallyIV then switch to oral when possible, inpatient then outpatient, 2-4 weeks of treatment
26
Q

Dog Bites

A
  • Localized cellulitis and pain
  • 5% become infected
  • Treat only if severe or co-morbidity
  • Likely pathogens: Pasteurella canis, S. aureus, Bacteroides spp.
27
Q

Dog Bite Treatment

A
  • Augmentin 875/125 mg BID or 500/125 TID po
  • PCN Allergy: Clinda 450 mg TID OR Clinda + Bacrim in children
  • *Other options for adults not listed**
  • Duration: 10-14days
  • Consider rabies?
28
Q

Cat Bites

A
  • Localized cellulitis and pain (osteo)
  • 80% become infected
  • Culture and treat empirically
  • Most like Pasteurella multocida or S. aureus
29
Q

Cat Bite Treatments

A
  • Augmentin: 875/125 mg BID or 500/125 mg TID PO
  • Cefuroxime axetil: 500 mg BID PO (NO CEPHALEXIN)
  • Doxycycline 100 mg BID PO
  • Duration 10-14 days
30
Q

Human Bites

A
  • Localized cellulitis and pain, purulent discharge, decreased range of motion (osteo, septic arthritis, tenosynovitis
  • More serious than animal bites with higher rates of infection
  • Likely pathogens: Viridans strept, S. epidermidis, corynebacterium, S. aureus, eikenella, Bacteroides spp., peptostreptococcus
31
Q

Human Bite Wound Treatment

A
  • General: cleaning, irrigation, debridement

- Early (not infected): Augmentin 875/125 mg BID PO x 5 days

32
Q

Human Bites: Late Treatment

A

-Signs of infection, usually within 12-24 hours
-Unasyn: 1.5-3g IV q6h
OR
-Cefoxitin 1g IV q8h
OR
-Zosyn 3.375 IV q6h or 4hr infusion 3.375g IV q8h
-PCN allergy: Clinda 600-900mg IV q8h + Cipro 400 mg IV q12h OR Bactrim 10 mg/kg/day